Oral chemotherapeutic agents in elderly acute myeloid leukemia (AML) patients, a study from a developing country

被引：0
|
作者：
Mukhopadhyay, S. [1 ]
Chitalkar, P. [1 ]
Gupta, P. [1 ]
Roy, U. [1 ]
Mukhopadhyay, A. [1 ]
机构：
[1] Netaji Subhash Chandra Bose Canc Res Inst, Kolkata, India
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7057
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Durable Response with Venetoclax in Combination with Decitabine or Azacitidine in Elderly Patients with Acute Myeloid Leukemia (AML)
    DiNardo, Courtney D.
    Pratz, Keith
    Potluri, Jalaja
    Pullarkat, Vinod
    Jonas, Brian A.
    Wei, Andrew H.
    Becker, Pamela S.
    Frankfurt, Olga
    Xu, Tu
    Hong, Wan-Jen
    Chyla, Brenda
    Pollyea, Daniel A.
    Letai, Anthony
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S201 - S201
  • [42] UPDATED RESULTS FROM A PHASE 2 STUDY OF PRACINOSTAT (P) IN COMBINATION WITH AZACITIDINE (AZA) IN ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML)
    Garcia-Manero, G.
    Atallah, E.
    Khaled, S.
    Arellano, M.
    Patnaik, M.
    Esquibel, V.
    Wood, K.
    Medeiros, B.
    HAEMATOLOGICA, 2015, 100 : 216 - 216
  • [43] Durable response with venetoclax in combination with decitabine or azacitadine in elderly patients with acute myeloid leukemia (AML).
    Dinardo, Courtney Denton
    Pratz, Keith William
    Potluri, Jalaja
    Pullarkat, Vinod A.
    Jonas, Brian Andrew
    Wei, Andrew H.
    Becker, Pamela Sue
    Frankfurt, Olga
    Xu, Tu
    Hong, Wan-Jen
    Chyla, Brenda
    Pollyea, Daniel Aaron
    Letai, Anthony G.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [44] Prognosis factor study in acute myeloid leukemia (AML).
    Lacombe, F
    Marit, G
    Dumain, P
    Faberes, C
    Boiron, JM
    Belloc, F
    ConyMakhoul, P
    BilhouNabera, C
    Bernard, P
    Reiffers, J
    BLOOD, 1997, 90 (10) : 284 - 284
  • [45] Outcome of elderly patients (age>70) treated for acute myeloid leukemia (AML):: A retrospective study of 126 patients
    Etienne, A.
    Charbonnier, A.
    Retomaz, F.
    Sainty, D.
    Mozziconacci, M. J.
    Coso, D.
    Stoppa, A. M.
    Aurran, T.
    D'Incan, E.
    Doglio, M. F.
    Gastaut, J. A.
    Vey, N.
    ANNALS OF HEMATOLOGY, 2006, 85 : 23 - 24
  • [46] A Conventional Cytogenetic Study of Acute Myeloid Leukemia (AML) in 340 Brazilian patients
    Schmid-Braz, Ana Teresa
    Wuicik-Merfort, Lismeri
    Borgonovo, Tamara
    Jamur, Valderez R.
    Caporal, Fernando Augusto
    Cavalli, Iglenir Joao
    Beltrame, Miriam
    Malvezzi, Marister
    CHROMOSOME RESEARCH, 2013, 21 : S77 - S77
  • [47] Correlative Biomarkers of Response to Venetoclax (VEN) in Combination with Chemotherapy or Hypomethylating Agents (Hma) in Elderly Untreated Patients with Acute Myeloid Leukemia (AML)
    Chyla, B.
    Popovic, R.
    Potluri, J.
    Hayslip, J.
    Huang, X.
    Mabry, M.
    Bhathena, A.
    ANNALS OF HEMATOLOGY, 2017, 96 : S84 - S85
  • [48] An open, phase I study of cediranib in patients with acute myeloid leukemia (AML)
    Fiedler, Walter
    Mesters, Rolf
    Heuser, Michael
    Ehninger, Gerhard
    Ottman, Oliver G.
    Berdel, Wolfgang E.
    Zirrgiebel, Ute
    Robertson, Jane
    Puchalski, Thomas A.
    Brave, Sandra R.
    Juergensmeier, Juliane M.
    Serve, Hubert
    BLOOD, 2007, 110 (11) : 273A - 273A
  • [49] Outcome of Elderly Patients after Failure to Hypomethylating Agents Given As Frontline Therapy for Acute Myeloid Leukemia (AML): Single Institution Experience
    Nanah, Rama
    McCullough, Kristen B.
    Hogan, William J.
    Begna, Kebede H.
    Gangat, Naseema
    Patnaik, Mrinal M.
    Elliott, Michelle Ann
    Litzow, Mark
    Al-Kali, Aref
    BLOOD, 2016, 128 (22)
  • [50] The Treatment of Elderly Patients With Acute Myeloid Leukemia
    Krug, Utz
    Buechner, Thomas
    Berdel, Wolfgang E.
    Mueller-Tidow, Carsten
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2011, 108 (51-52): : 863 - U11
12345